Vital Farms stock price target maintained at $15 by BMO Capital

BMO Capital maintained an Outperform rating and $15 price target on Vital Farms (VITL) after its Q3 results. Revenue was $182M, meeting expectations, and adjusted EBITDA was $1.5M, slightly above estimates. The company lowered fiscal 2026 revenue guidance to $730M and adjusted EBITDA guidance to negative $15M. VITL stock is down 69% YTD, trading at $10.02.

Original reporting
Published Nov 4, 2026, 10:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 10:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$VITL
Bearish
high confidence
Mentioned
$VITL
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$VITLBearishMed
01

Why it matters

The earnings miss and lowered guidance signal weaker demand and higher operating costs, likely prompting a sell‑off.

02

Market read

The earnings and guidance update provide fresh material for traders to reassess VITL's valuation.

03

What to watch

Potential upside from a lower cost base or strategic partnership not disclosed in the release.

Relevance 6/10Novelty 7/10Timing: pre-market today

Background

Vital Farms (NASDAQ:VITL) is a producer of pasture‑raised eggs and butter, recently facing cash‑burn concerns.

Company-level read

Ticker impact

$VITLBearishHigh confidence
Context

BMO Capital reiterated Outperform and a $15 price target after Vital Farms reported Q3 results and cut full-year revenue and EBITDA guidance.

Expected impact

likely pressure as the market prices in lower revenue and EBITDA forecasts

Evidence & confidence

The company lowered FY2026 revenue to $730M and projected negative EBITDA, indicating weaker fundamentals.

Market effects

The guidance cut may weigh on the specialty food sector and other small-cap consumer brands.

Impact is primarily on U.S. small-cap equities.

Limited to investors tracking US-listed niche consumer companies.

Counterpoint

If the market overreacts to the guidance cut, the stock could rebound on a short‑cover rally.

Key entities

  • BMO Capital

    Maintained Outperform rating and $15 price target.

Related articles

$VITLHigh

US egg supplier Vital Farms issues profit warning

Vital Farms reduced its full-year revenue forecast to $730m from $775m-$800m and expects an adjusted EBITDA loss of $15m, down from a previous gain estimate. Q3 revenue fell 8.4% to $182.2m, with a net loss of $6.5m. The company cited delayed new listings and conservative sales assumptions. Vital Farms withdrew its 2030 targets but expects sequential improvement in Q4.

$VITLMed

Vital Farms (VITL) Q3 2026 Earnings Call Transcript

Vital Farms (VITL) reported Q3 2026 net revenue of $182.2M, up 10% from Q2 but down 8.4% YoY. Adjusted EBITDA improved to $1.5M from a Q2 loss of $26.6M. The company cited market conditions, including lower egg prices and reduced consumer spending, as factors affecting performance. Vital Farms reduced full-year guidance to ~$730M due to changes in demand, distribution timing, and market pricing. The company withdrew 2030 financial targets, focusing on near-term execution.

$VITLMedAI 8/10

Vital Farms Q3 Earnings Call Highlights

Vital Farms (VITL) lowered its full-year net-sales outlook to $730M and adjusted EBITDA to a $15M loss. Management cited weaker holiday demand, delayed distribution, and stable conventional egg prices. Q4 expectations include 175+ TDPs, 25.9 unit velocity, and $200 dollar velocity. The company paused capacity spending and withdrew 2030 targets, focusing on near-term execution.

$VITLMed

Vital Farms Reports Third Quarter 2026 Financial Results

Vital Farms, Inc. (VITL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Vital Farms Reports Third Quarter 2026 Financial Results Third Quarter Net Revenue of $182.2 Million, Up 9.7% Sequentially from the Second Quarter Reaches Record Dollar and Volume Share of the Shell Egg Category Updates Fiscal Year 2026 Net Revenue Outlook to around $730 Million

$VITLMedAI 8/10

Vital Farms’s (NASDAQ:VITL) Q3 2026 earnings results: revenue in line with expectations but stock drops 10.4%

Vital Farms (VITL) reported Q3 2026 revenue of $182.2M, matching estimates but down 8.4% YoY. EPS missed at -$0.15 vs -$0.12 expected. Adjusted EBITDA was $1.5M, slightly below estimates. The company lowered full-year revenue guidance to $730M from $787.5M, with EBITDA guidance of -$15M, below expectations. Operating margin fell to -4.2% from 10.8% YoY, and free cash flow was -$22.79M.